TruAlt Bioenergy sells Unit 5 to Onkar Agro for ₹171 crore
TruAlt Bioenergy Limited divests non-core Unit 5 to Onkar Agro Sugars & Energy for ₹171 crore to repay a ₹135 crore IREDA loan. The unit contributed zero revenue in FY26 but held net assets worth ₹159.32 crore. The deal, approved on August 4, 2026, aims to reduce debt burden and improve liquidity, with completion expected by November 4, 2026.

*this image is generated using AI for illustrative purposes only.
TruAlt Bioenergy Limited company name has approved the slump sale of its Unit 5, located in Muttalageri Village, Badami Taluka, Karnataka, to Onkar Agro Sugars & Energy Private Limited for an aggregate consideration of ₹171 crore. The Board of Directors ratified the transaction during its meeting on August 4, 2026, marking a strategic move to divest a non-core asset that currently generates no revenue but carries significant debt obligations.
The primary driver behind the divestment is the reduction of financial liabilities associated with the unit. Unit 5 holds an outstanding term loan of approximately ₹135 crore from the Indian Renewable Energy Development Agency Limited (IREDA). Management stated that the interest costs on this loan have adversely impacted profitability and cash flows. By selling the undertaking as a going concern, including land, buildings, plant, and machinery, the company intends to utilize the proceeds primarily to repay this debt, with the remaining balance deployed toward core business operations and high-growth opportunities.
Transaction Details
The sale is structured as a slump sale under Section 2(42A) of the Income Tax Act, though specific tax implications were not detailed in the filing. The transaction is subject to customary closing adjustments, fulfillment of conditions precedent, and receipt of necessary statutory and regulatory approvals. An Memorandum of Understanding (MOU) was executed on August 4, 2026, with definitive agreements to follow after due diligence.
| Particulars | Details |
|---|---|
| Seller | TruAlt Bioenergy Limited |
| Buyer | Onkar Agro Sugars & Energy Private Limited |
| Asset | Unit 5 (Muttalageri Village, Badami Taluka, Karnataka) |
| Consideration | ₹171 crore (subject to closing adjustments) |
| Outstanding Debt | ₹135 crore (term loan from IREDA) |
| Expected Completion | November 4, 2026 |
The buyer, Onkar Agro Sugars & Energy Private Limited, is not related to the promoters or group companies of TruAlt Bioenergy, confirming the transaction is at arm's length. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Financial Impact and Strategic Rationale
Unit 5 contributed nil turnover or revenue during the financial year ended March 31, 2026. However, its carrying value of net assets stood at ₹159.32 crore, representing 10.53% of the company’s total net worth as of March 31, 2026. The divestment allows the company to shed a liability-heavy asset that was draining resources without contributing to top-line growth.
What the Numbers Show
The disparity between the sale consideration of ₹171 crore and the outstanding debt of ₹135 crore suggests a potential immediate improvement in net cash position, assuming no other significant liabilities are attached to the unit. By removing ₹135 crore of debt from its books, the company is expected to see a reduction in finance costs, which should positively impact future earnings before interest and taxes (EBIT) and overall cash flow generation. This aligns with management’s stated goal of enhancing operational efficiency and capital allocation.
The company expects to complete the disposal by November 4, 2026. Further details regarding the definitive agreement and final consideration adjustments will be disclosed upon execution. The information is also available on the company’s website.
Historical Stock Returns for Trualt Bioenergy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.22% | +3.72% | -7.12% | +8.51% | -17.71% | -17.71% |
How will the ₹36 crore net proceeds from the Unit 5 sale be specifically allocated between debt repayment and high-growth core business initiatives?
What are the potential tax liabilities or benefits arising from structuring this transaction as a slump sale under Section 2(42A) of the Income Tax Act?
Will the removal of Unit 5's interest obligations significantly improve TruAlt Bioenergy's EBITDA margins in the upcoming fiscal quarters?


































